Market revenue in 2024 | USD 164.8 million |
Market revenue in 2030 | USD 177.6 million |
Growth rate | 1.3% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 54.07% in 2024. Horizon Databook has segmented the Italy hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
Italy's HAI diagnostics market is evolving rapidly due to increasing hospital admissions and a growing prevalence of antibiotic-resistant pathogens. The Italian healthcare system is under pressure to improve patient safety standards, leading to greater investment in diagnostic technologies capable of detecting HAIs more effectively.
The market is expected to grow steadily as hospitals adopt more sophisticated testing methods such as immunoassays and PCR-based tests to combat rising infection rates. Major players in Italy include global firms and local companies specializing in infectious disease testing.
The competitive landscape is shaped by ongoing technological advancements and regulatory support aimed at enhancing infection control measures within healthcare facilities. As hospitals strive for higher standards of care, the demand for accurate and rapid diagnostic solutions will continue to drive market growth in Italy.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Italy hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account